Radford joins Nanosonics
Thursday, 05 June, 2008
Nanosonics Ltd (ASX: NAN) has appointed a new CEO to lead the disinfection technology company's latest product roll-out.
The new CEO, David Radford, has 20 years of experience in the medical device and healthcare industries. He also has an honours degree in applied biological science from Bristol Polytechnic.
The company said Radford has extensive experience driving rapid growth in the ultrasound product market, which makes him the perfect person to oversee the company's roll-out of its new ultrasound disinfection devices.
Radford takes the helm from Nanosonics CFO Chris Grundy, who had been acting as CEO, and from Dr David Fisher, who had taken on the role of interim executive director.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
